blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2029169

EP2029169 - RECOMBINANT VIRAL VACCINE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.03.2014
Database last updated on 11.09.2024
Most recent event   Tooltip28.03.2014Application deemed to be withdrawnpublished on 30.04.2014  [2014/18]
Applicant(s)For all designated states
TRANSGENE S.A.
Boulevard Gonthier d'Andernach Parc d'Innovation, CS80166
67405 Illkirch Graffenstaden Cedex / FR
[2010/14]
Former [2009/10]For all designated states
TRANSGENE S.A.
11, rue de Molsheim
67082 Strasbourg Cédex / FR
Inventor(s)01 / BONNEFOY, Jean-Yves
29, rue Finkwiller
F-67000 Strasbourg / FR
02 / PAUL, Stéphane
27, rue Bautain
F-67000 Strasbourg / FR
 [2009/10]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2009/10]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date07764675.015.06.2007
[2009/10]
WO2007EP05303
Priority number, dateEP2006036002820.06.2006         Original published format: EP 06360028
US20060852964P20.10.2006         Original published format: US 852964 P
[2009/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007147529
Date:27.12.2007
Language:EN
[2007/52]
Type: A2 Application without search report 
No.:EP2029169
Date:04.03.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 27.12.2007 takes the place of the publication of the European patent application.
[2009/10]
Search report(s)International search report - published on:EP28.02.2008
ClassificationIPC:A61K39/00, A61K39/12, C07K14/005, C12N7/00, A61K39/39
[2013/25]
CPC:
A61K39/39 (EP,US); A61K39/275 (KR); A61K31/437 (KR);
A61K39/0011 (EP,KR,US); A61K39/12 (EP,US); A61P31/12 (EP);
A61P31/22 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/04 (EP); A61P43/00 (EP); C07K14/005 (EP,US);
C12N7/00 (EP,US); A61K2039/5256 (EP,US); A61K2039/54 (EP,US);
A61K2039/55511 (EP,US); A61K2039/55533 (EP,US); A61K2039/585 (EP,US);
C12N2710/14143 (EP,US); C12N2710/20022 (EP,US); C12N2710/20034 (EP,US) (-)
Former IPC [2009/10]A61K39/39, A61K39/285
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/10]
Extension statesHR09.12.2008
RS09.12.2008
TitleGerman:REKOMBINANTER VIRALER IMPFSTOFF[2009/10]
English:RECOMBINANT VIRAL VACCINE[2009/10]
French:VACCIN VIRAL RECOMBINANT[2009/10]
Entry into regional phase09.12.2008National basic fee paid 
09.12.2008Designation fee(s) paid 
09.12.2008Examination fee paid 
Examination procedure15.04.2008Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.12.2008Amendment by applicant (claims and/or description)
09.12.2008Examination requested  [2009/10]
16.10.2009Despatch of a communication from the examining division (Time limit: M04)
25.02.2010Reply to a communication from the examining division
29.12.2011Despatch of a communication from the examining division (Time limit: M06)
06.07.2012Reply to a communication from the examining division
15.01.2013Despatch of a communication from the examining division (Time limit: M04)
03.05.2013Reply to a communication from the examining division
18.06.2013Communication of intention to grant the patent
29.10.2013Application deemed to be withdrawn, date of legal effect  [2014/18]
04.12.2013Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2014/18]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.10.2009
Fees paidRenewal fee
24.06.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
27.06.2011Renewal fee patent year 05
22.06.2012Renewal fee patent year 06
24.06.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0224225  (GLAXO GROUP LTD [GB], et al);
 [X]WO03080114  (POWDERJECT RES LTD [GB], et al);
 [DA]WO2005018574  (3M INNOVATIVE PROPERTIES CO [US]);
 [DX]WO2006042254  (3M INNOVATIVE PROPERTIES CO [US], et al);
by applicantUS3854480
 US4452775
 US4675189
 US4689338
 US4929624
 EP0385630
 US5075109
 US5133974
 WO9215672
 WO9417043
 US5407686
 WO9527780
 US5736152
 US6207646
 WO0122972
 WO0224225
 US2003139364
 WO03080114
 US2004076633
 WO2005018574
 US6913752
 WO2006042254
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.